-
A new generation of blood tests can help doctors diagnose Alzheimer's without a brain scan or spinal tap. But only a few perform as well as traditional tests.
-
Biomarker testing is a tool that doctors use to get a clearer picture of a medical problem — often cancer.
-
The experimental drug lecanemab was able to slow down Alzheimer's in a large study. Many researchers think the drug will become the first to help large numbers of patients.
-
In a large study, the experimental Alzheimer's drug lecanemab reduced the rate of cognitive decline by 27 percent in people in the early stages of the disease.
-
Researchers are launching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease.
-
The lead author of a new study on the neurological impact of COVID-19 infection says that the disease "is not as benign" as people may think.
-
The promising study of the drug could reduce the cognitive effects of Alzheimer's disease.
-
For some people, a rare genetic mutation makes dementia inescapable. Three sisters have decided to confront fate with a genetic test and have joined a research project on possible treatments.
-
In stressful times, it's helpful to be reminded of the good people willing to help out. That's the theme of a new podcast from the team at Hidden Brain. It's called: My Unsung Hero.
-
Microglia are amoeba-like cells that scour the brain for injuries and invaders. But sometimes the usually helpful cells go into overdrive and damage the brain, researchers say.